E. Hawkins

Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).

L. Mofenson, C. Fletcher, M. Fowler, 2000, The Journal of infectious diseases.

Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.

W. Borkowsky, L. Mofenson, D. Francis, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.

S. Blanchard, S. Nachman, E. Abrams, 2003, Pediatrics.

Long Term Tolerability and Safety of Enfuvirtide for Human Immunodeficiency Virus 1-Infected Children

M. Hughes, J. Church, L. Mofenson, 2004, The Pediatric infectious disease journal.

Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in human immunodeficiency virus 1-infected children

M. Hughes, J. Church, L. Mofenson, 2002, The Pediatric infectious disease journal.

Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.

J. Lambert, S. Gurunathan, G. Tomaras, 2005, The Journal of infectious diseases.

Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353

P. Sax, D. Haas, E. Acosta, 2019, The Journal of antimicrobial chemotherapy.

Atazanavir Pharmacokinetics With and Without Tenofovir During Pregnancy

Chengcheng Hu, E. Capparelli, S. Burchett, 2011, Journal of acquired immune deficiency syndromes.

Pharmacokinetics of tenofovir during pregnancy and postpartum

M. Mirochnick, C. Hu, E. Hawkins, 2015, HIV medicine.

CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3–36 months with HIV infection

W. Borkowsky, S. Spector, E. Capparelli, 2017, AIDS.

Raltegravir Pharmacokinetics During Pregnancy

F. Aweeka, D. H. Watts, E. Capparelli, 2014, Journal of acquired immune deficiency syndromes.

Safety and immunogenicity of HIV recombinant envelope vaccines in HIV- infected infants and children

J. Lambert, W. Borkowsky, D. Francis, 1998 .

Pharmacokinetics of an Increased Atazanavir Dose With and Without Tenofovir During the Third Trimester of Pregnancy

D. H. Watts, S. Burchett, T. Cressey, 2013, Journal of acquired immune deficiency syndromes.

Loss to follow-up among infants in a study of isoniazid prophylaxis (P1041) in South Africa.

B. Zeldow, S. Nachman, A. Violari, 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.